Upon arrival to the OSH, initial vitals 100.3 tm 104.9, 165/68 92 16 96%2L, FS 110,  the pt received a dose of Zosyn 3.375mg, KCL 20meq, 1L NS, and the pt was subsequently transferred to [**Hospital1 18**] for presumed ascending cholangitis.
Upon arrival initial vitals 100.8 137/92 98 18 98% on RA.
WBC 25, TB 4.9, Cr 1.7, Lactate 2.2, UA neg, RUQ revealed stent remains in CBD and a dilated intrahepatic duct.
Subsequently the pt SBP dropped to 70, received 4L of NS, 40meq KCl,  Foley with 200cc UOP.
Prior to transfer to the floor vitals 82 108/47 98% RA on .12 of Levophed.
Family History: No history of pancreatic or liver cancers History of DM2, otherwise non-contributory   Physical Exam: T=97.8 BP=161/52 (Levophed .12) HR=75  RR=16 O2= 98 2L PHYSICAL EXAM GENERAL: Pleasant, well appearing eldery female in NAD HEENT: Normocephalic, atraumatic.
LUNGS: Clear anteriorly ABDOMEN: Tenderness to palpation in RUQ.
PSYCH: Listens and responds to questions appropriately, pleasant  Pertinent Results: [**2106-11-25**] 11:45PM   WBC-25.4*# RBC-3.34* HGB-10.2* HCT-30.4* MCV-91 MCH-30.4 MCHC-33.4 RDW-15.1 [**2106-11-25**] 11:45PM   NEUTS-95* BANDS-0 LYMPHS-4* MONOS-1* EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2106-11-25**] 11:45PM   PLT SMR-NORMAL PLT COUNT-184 [**2106-11-25**] 11:45PM   PT-14.7* PTT-27.8 INR(PT)-1.3* [**2106-11-25**] 11:45PM URINE  BLOOD-MOD NITRITE-NEG PROTEIN-75 GLUCOSE-NEG KETONE-NEG BILIRUBIN-SM UROBILNGN-NEG PH-5.0 LEUK-NEG [**2106-11-25**] 11:45PM URINE  RBC-0-2 WBC-[**1-21**] BACTERIA-FEW YEAST-NONE EPI-0-2 [**2106-11-25**] 11:45PM   ALT(SGPT)-191* AST(SGOT)-120* ALK PHOS-169* TOT BILI-4.9* [**2106-11-25**] 11:45PM   LIPASE-31 [**2106-11-25**] 11:45PM   GLUCOSE-56* UREA N-29* CREAT-1.7* SODIUM-138 POTASSIUM-2.9* CHLORIDE-105 TOTAL CO2-19* ANION GAP-17 [**2106-11-25**] 11:51PM   LACTATE-2.2* [**2106-11-26**] 05:54AM BLOOD Cortsol-10.8 .
Cannulation of the biliary duct was performed with a sphincterotome after a guidewire was placed.
Contrast medium was injected resulting in complete opacification.
Discharge Day Laboratories: [**2106-12-3**] WBC-7.3 RBC-3.51* Hgb-10.2* Hct-32.3* MCV-92 Plt Ct-260 [**2106-12-3**] Glucose-58* UreaN-16 Creat-1.2* Na-142 K-3.5 Cl-103 HCO3-29  Brief Hospital Course: 86F with hx of pancreatic CA s/p biliary stenting presenting with ascending cholangitis.
Initial lactate 2.2, trended down to 1.8.
# Gap Metabolic Acidosis: Bicarb of 17 on initial labs with gap of 14.
Anion gap improved over 24 hours.
BUN at 29 up from 12.
She underwent CT A/P with contrast to discern if mass had grown or spread.
She was noted to have a right adnexal mass on abdominal CT; follow-up pelvic ultrasound was non-diagnostic.
Calcium 600 + D(3) Ergocalciferol (Vitamin D2)  Oral Multi-Vitamin HP/Minerals     Capsule Oral Omega-3 Fatty Acids  Oral  Discharge Medications: 1.
You also underwent further evaluation of your pancreatic cancer with oncology consultation and CT scan.
Followup Instructions: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**Telephone/Fax (1) 22**] [**2106-12-16**] 10:30 PCP: [**Name10 (NameIs) **],[**Name11 (NameIs) **] [**Name Initial (NameIs) **].
[**Telephone/Fax (1) 14916**]   [**2106-12-8**] at 2:15 [**Name6 (MD) **] [**Name8 (MD) **], MD Phone:[**Telephone/Fax (1) 463**] Date/Time:[**2106-12-15**] 9:30
